WMB
58
3
CSCO
63
5
JPM
59
6
DGX
28
4
CLX
65
2
R
55
-2
ZBH
69
15
HES
49
2
ORLY
48
3
AN
49
2
CHRW
53
2
FMC
23
7
MTCH
62
22
PNR
56
2
MSI
52
3
EBAY
42
2
GT
43
2
THC
52
9
GD
42
4
AIG
38
5
WMB
58
3
CSCO
63
5
JPM
59
6
DGX
28
4
CLX
65
2
R
55
-2
ZBH
69
15
HES
49
2
ORLY
48
3
AN
49
2
CHRW
53
2
FMC
23
7
MTCH
62
22
PNR
56
2
MSI
52
3
EBAY
42
2
GT
43
2
THC
52
9
GD
42
4
AIG
38
5
Financhill
Back

MDxHealth SA 10K Form

Buy
53

MDXH
MDxHealth SA

Last Price:
$2.2500
Seasonality Move:
-21.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDXH News And Ratings

See the #1 stock for the next 7 days that we like better than MDXH

MDXH Financial Statistics

Sales & Book Value

Annual Sales: $70.2M
Cash Flow: $-5.8M
Price / Cash Flow: 0
Annual Sales: $0.36
Price / Book: 6.61

Profitability

EPS (TTM): -1.52000
Net Income (TTM): $-41.9M
Gross Margin: $43.9M
Return on Equity: -650.14%
Return on Assets: -31.08%

MDxHealth SA Earnings Forecast

Key MDxHealth SA Financial Ratios

  • The Gross Profit Margin over the past 20 years for MDXH is 62.58%.
  • The Selling, General & Administrative Expenses for MDXH have been equal to 83.06% of Gross Profit Margin.
  • The Research & Development expenses have been 9.08% of Revenue.
  • The Interest Expense is -12.95% of Operating Income.
  • The Net Earning history of MDXH is -61.40% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

MDxHealth SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDXH
Website: mdxhealth.com

Debt

Debt-to-Equity Ratio: 3.02
Current Ratio: 1.54
Quick Ratio: 1.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDXH Technical Analysis vs Fundamental Analysis

Buy
53
MDxHealth SA (MDXH) is a Buy

Is MDxHealth SA a Buy or a Sell?

  • MDxHealth SA stock is rated a Buy
    The current MDxHealth SA [MDXH] share price is $2.2700. The Score for MDXH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.